Compare BOTJ & STRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | BOTJ | STRO |
|---|---|---|
| Founded | 1998 | 2003 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 71.6M | 85.0M |
| IPO Year | 2015 | N/A |
| Metric | BOTJ | STRO |
|---|---|---|
| Price | $20.74 | $20.45 |
| Analyst Decision | | Hold |
| Analyst Count | 0 | 8 |
| Target Price | N/A | ★ $18.88 |
| AVG Volume (30 Days) | 4.9K | ★ 116.6K |
| Earning Date | 05-05-2026 | 01-01-0001 |
| Dividend Yield | ★ 1.94% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 1.39 | N/A |
| Revenue | ★ $4,003,000.00 | N/A |
| Revenue This Year | N/A | $63.08 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $14.85 | ★ N/A |
| Revenue Growth | ★ 2.61 | N/A |
| 52 Week Low | $12.80 | $0.52 |
| 52 Week High | $21.49 | $20.59 |
| Indicator | BOTJ | STRO |
|---|---|---|
| Relative Strength Index (RSI) | 52.31 | 73.10 |
| Support Level | $20.00 | $0.76 |
| Resistance Level | $21.47 | N/A |
| Average True Range (ATR) | 0.57 | 1.70 |
| MACD | -0.10 | 0.27 |
| Stochastic Oscillator | 13.10 | 94.68 |
Bank of the James Financial Group Inc is a bank holding company that provides retail and commercial banking, deposit services, lending services, mortgage brokerage services, and other banking services. The company provides a range of deposit services including checking accounts, savings accounts and other time deposits of various types, ranging from daily money market accounts to longer-term certificates of deposit. It offers various types of secured and unsecured consumer loans, including personal loans, lines of credit, overdraft lines of credit, automobile loans, installment loans, demand loans, and home equity loans. It operates three business segments community banking; mortgage banking, and investment advisory services.
Sutro Biopharma Inc is a clinical-stage drug discovery, development, and manufacturing company. It is mainly engaged in the development of biopharmaceutical products. The company manufactures next-generation protein therapeutics for cancer and autoimmune disorders through its proprietary integrated cell-free protein synthesis platform, XpressCF. Products offered by the company include STRO-001 for patients with multiple myeloma and non-Hodgkin lymphoma and STRO-002 for the treatment of ovarian and endometrial cancers. The company also pipeline contains STRO-004, STRO-006, STRO-00X, STRO-00Y, STRO-003, VAX24, VAX31, and Others.